Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.98B |
| 2 |
Meta Platforms (Facebook)
META
|
+$997M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$860M |
| 4 |
Workday
WDAY
|
+$691M |
| 5 |
Amazon
AMZN
|
+$616M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$498M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$420M |
| 3 |
FedEx
FDX
|
+$350M |
| 4 |
Vale
VALE
|
+$340M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$322M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.96% |
| 2 | Technology | 2.07% |
| 3 | Consumer Discretionary | 1.49% |
| 4 | Financials | 1.12% |
| 5 | Communication Services | 1.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LX
12076
CALL
LexinFintech Holdings
LX
$194M
| $66K | ﹤0.01% |
25,200
-107,700
| -81% | -$357K |
|
12077
CALL
Nautilus Biotechnolgy
NAUT
$113M
| $66K | ﹤0.01% |
15,300
-9,900
| -39% | -$40.6K |
|
12078
CALL
Puma Biotechnology
PBYI
$468M
| $66K | ﹤0.01% |
+22,900
| New | +$59.2K |
|
|
WIMI
12079
CALL
WiMi Hologram Cloud
WIMI
$23.9M
| $66K | ﹤0.01% |
2,460
+1,340
| +120% | +$36.1K |
|
|
AUD
12080
CALL
DELISTED
Audacy, Inc.
AUD
| $66K | ﹤0.01% |
+22,800
| New | +$60.2K |
|
|
CLLS
12081
PUT
Cellectis
CLLS
$342M
| $65K | ﹤0.01% |
14,400
-2,700
| -16% | -$14.9K |
|
|
DRRX
12082
CALL
DELISTED
DURECT Corp
DRRX
| $65K | ﹤0.01% |
9,740
+1,060
| +12% | +$7.37K |
|
12083
Geospace Technologies
GEOS
$68.3M
| $65K | ﹤0.01% |
+11,352
| New | +$74.8K |
|
12084
PUT
Protalix BioTherapeutics
PLX
$205M
| $65K | ﹤0.01% |
61,700
-11,400
| -16% | -$10.4K |
|
12085
PharmaCyte Biotech
PMCB
$5.53M
| $65K | ﹤0.01% |
+28,062
| New | +$62.3K |
|
12086
CALL
RAVE Restaurant Group
RAVE
$44.5M
| $65K | ﹤0.01% |
60,600
+39,000
| +181% | +$40.5K |
|
12087
CALL
Turkcell
TKC
$4.7B
| $65K | ﹤0.01% |
+16,800
| New | +$60K |
|
12088
Village Farms International
VFF
$356M
| $65K | ﹤0.01% |
12,231
-276,783
| -96% | -$1.49M |
|
|
VNET
12089
VNET Group
VNET
$1.86B
| $65K | ﹤0.01% |
11,100
-135,641
| -92% | -$1.04M |
|
|
GENE
12090
DELISTED
Genetic Technologies Ltd.
GENE
| $65K | ﹤0.01% |
6,579
+1,187
| +22% | +$11.5K |
|
|
OBSV
12091
PUT
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $65K | ﹤0.01% |
43,000
-75,700
| -64% | -$112K |
|
12092
CALL
BBVA Argentina
BBAR
$2.96B
| $64K | ﹤0.01% |
17,900
-87,000
| -83% | -$283K |
|
12093
CALL
StealthGas
GASS
$353M
| $64K | ﹤0.01% |
+26,500
| New | +$58.3K |
|
|
HEPA
12094
DELISTED
Hepion Pharmaceuticals
HEPA
| $64K | ﹤0.01% |
49
-40
| -45% | -$44.2K |
|
12095
Intellicheck
IDN
$57.6M
| $64K | ﹤0.01% |
25,013
-6,587
| -21% | -$24K |
|
12096
Jaguar Health
JAGX
$4.19M
| – | – |
0
| – | – |
|
|
JFIN
12097
PUT
Jiayin Group
JFIN
$110M
| $64K | ﹤0.01% |
22,800
-1,500
| -6% | -$3.35K |
|
|
JG
12098
Aurora Mobile
JG
$38.6M
| $64K | ﹤0.01% |
2,924
-2,738
| -48% | -$55.6K |
|
12099
PUT
MediWound
MDWD
$163M
| $64K | ﹤0.01% |
4,614
+1,785
| +63% | +$28.9K |
|
12100
PUT
Noodles & Co
NDLS
$88.2M
| $64K | ﹤0.01% |
+1,338
| New | +$82.1K |
|
Similar funds
Jeff Yass's Q1 2022 Portfolio in Review
As of Q1 2022, Jeff Yass held 14,706 positions worth $578B, down 13% from $667B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Jeff Yass's Q1 2022 filing shows 1,657 new, 4,873 increased, 6,001 reduced and 1,835 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 1,089,723 shares worth $107M. The largest sale was Walt Disney, an estimated $498M.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q1 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 1,089,723 shares worth $107M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.98B increase.
- Jeff Yass's biggest Q1 2022 reduction was Walt Disney, cutting an estimated $498M.
- Jeff Yass fully exited Xilinx Inc in Q1 2022, selling an estimated $217M.
- Jeff Yass's ten largest holdings make up 34% of its $578B portfolio in Q1 2022.
- Jeff Yass opened 1,657 new positions and closed 1,835 in Q1 2022.
- Jeff Yass's portfolio value fell 13% quarter-over-quarter to $578B.
Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.